Halteres Associates

San Ramon, CA

NULISA: Unlocking The Proteome

Client: Alamar Biosciences

Category: Non-Broadcast | Long Form Videos > 3 Minutes | 125. Medical

About Project

The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation. By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.

Credits

Vinnie Urdea (Creative Director / Halteres Associates)
Mickey Urdea (Founding Partner / Halteres Associates)
Yuriy Svidinenko (Animator / Nanobot Medical Animation)